(Date:11/20/2008)...Newswire/ -- Want to lower your risk for type,2 d...tes of physical activity,three times a day. Ten t...at,the U.S. Centers for Disease Control and Preve...sure, manage your cholesterol and lose weight. , ...le have diabetes, and heart,disease is the leadin...
(Date:11/20/2008)...nt to undergo a routine but painful colonoscopy &...ng to the American Cancer Society, colon cancer is...n and women and kills about 50,000 Americans every...have no symptoms or family history," says Prof. Na...ology, at Tel Aviv University,s Sackler Faculty of...
(Date:11/20/2008)...E Ministries, Inc. (Hope for Orphans of Ethiopia),...n organization founded in January 2007, committed ...n of Ethiopia. , WILTON,...he Ethiopian AIDS pandemic has afflicted this coun...t countless numbers of homeless children living on...
(Date:11/20/2008)...PRNewswire-USNewswire/ -- The Gerstman Family was ...of their extraordinary dedication and contribution...ndation, the Lisa Beth Gerstman Foundation. , ...eature profiles those individuals who have made a ...nth, Dan Gerstman, co-founder of the Garden City, ...
Breaking Medicine News(10 mins):Health News:10 Minutes at a Time: Simple Steps to Get Moving and Reduce Your Risk of Diabetes and Heart Disease 2Health News:A simple blood test for colon cancer 2Health News: HOE Ministries Gives New Hope to Orphans in Ethiopia : Hope For Orphans of Ethiopia Organization to Build Greater Awareness and Solutions to the Soaring Poverty Catastrophe Afflicting Orphaned and Innocent Children in Prison 2Health News: HOE Ministries Gives New Hope to Orphans in Ethiopia : Hope For Orphans of Ethiopia Organization to Build Greater Awareness and Solutions to the Soaring Poverty Catastrophe Afflicting Orphaned and Innocent Children in Prison 3Health News:Gerstman Family Spotlighted on Reader's Digest Website 2...d Food Programme (WFP) today announced plans to as...food needs of people living in communities affect...od assistance due to the persistence of the drough... Government to ensure that food is available throu...
...rnational Development (DFID) in Britain has announ...) over five years in support of the third phase o...ol Programme (NACP III). The NACP III is a compr...rt programme to halt and begin to reverse the AIDS...
...friend Kate Middleton's curvaceous figure has sudd...en in style for her slender but athletic figure, i... recent appearances Kate appeared painfully thin, ...almost flat chested. And according to speculation...
...ity star Myleene Klass has followed in the footste...gnant. The 29-year-old I'm A Celebrity star, wea...lace, posed naked for Glamour magazine's British e...nk, 'Does my belly or my bum look big'. You just t...
Other Medicine News:(Date:11/19/2008)...Newswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) an...diary of,Takeda Pharmaceutical Company Limited (T... Phase 3 MONET1 trial evaluating motesanib (AMG 70... for the first-line treatment of,advanced non-sma...uspended,following a planned safety data review o...
(Date:11/19/2008)...indings on critical enzyme,s regulation may hold k...f disorders , , MEMPHIS, Tenn., Nov. 19 /PR...ildren,s Research Hospital have gained new insight...horses called calpains. , , As the cell,s ... cellular processes, including the movement of cel...
(Date:11/19/2008)... -- Isogen, a contract development and,manufactur...ced the first,phase launch of its contract facili...y address the process, facility and capacity probl...y-niched, low-volume clinical and,early-stage com...ompanies can invest over $100 million and four yea...
(Date:11/18/2008)...rstCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a spec...opment Company,and Sosei Group Corporation ("Sos...ional biopharmaceutical company, today announce th...re-clinical efficacy data for NSL-043/SD118.,This...europathic pain and has,successfully completed Ph...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Pennsylvania Insurance Department Announces New Web Page for Older Pennsylvanians 9057 1Pennsylvania Insurance Department Announces New Web Page for Older Pennsylvanians 9057 2ViroPharma Augments Senior Management 9054 1ViroPharma Augments Senior Management 9054 2ViroPharma Augments Senior Management 9054 3Pharmos Corporation Completes Initial Closing of Private Placement 2441 1Pharmos Corporation Completes Initial Closing of Private Placement 2441 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 1Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 3...stCall/ - Research,collaborators with Oncolytics B...r a poster presentation covering REOLYSIN(R),clini... Oncology,(ASCO) Annual Meeting, to be held June 1...of Oncolytics, U.K. Phase I systemic,administratio...a Phase I Study of,Wild-Type Oncolytic Reovirus Ad...
...1, 2007 - A therapeutic,vaccine developed by the G...es new hope for cancer patients. The results of a,...ented to an,international audience at the Annual C...ology (ASCO) in Chicago, USA. ASCO is the,most imp...ists,world-wide., The active substance VPM4001, an...
Other Medicine Technology:Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001 2Non-mydriatic stereo fundus camera for glaucoma detection at early stage.
Recently updated with a high resolution 1640 x 1280 digital CCD the new Kowa Non Myd - digital achieves new levels of image quality, style and ease of use. Now supplied complete with Kowa's own compr
Nidek offers 3-Dx Digital stereo camera to provide a complete and comprehensive digital imaging platform.
Eye Q PRO is the optimum choice for ophthalmologists and clinicians specializing in advanced pathology and research.
Medicine Products: